Singapore markets close in 2 hours 35 minutes

ATI Physical Therapy, Inc. (ATIP)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
4.1000-0.0700 (-1.68%)
At close: 03:51PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 17.26M
Enterprise value 730.64M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.02
Price/book (mrq)0.45
Enterprise value/revenue 1.05
Enterprise value/EBITDA 20.91

Trading information

Stock price history

Beta (5Y monthly) 0.26
52-week change 3-69.63%
S&P500 52-week change 321.23%
52-week high 314.8000
52-week low 34.0000
50-day moving average 36.0840
200-day moving average 37.1092

Share statistics

Avg vol (3-month) 36.04k
Avg vol (10-day) 38.33k
Shares outstanding 54.21M
Implied shares outstanding 64.21M
Float 81.42M
% held by insiders 12.99%
% held by institutions 178.47%
Shares short (28 Mar 2024) 47.66k
Short ratio (28 Mar 2024) 41.82
Short % of float (28 Mar 2024) 40.41%
Short % of shares outstanding (28 Mar 2024) 40.18%
Shares short (prior month 29 Feb 2024) 49.11k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:50
Last split date 315 Jun 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -10.15%
Operating margin (ttm)-0.50%

Management effectiveness

Return on assets (ttm)-1.78%
Return on equity (ttm)-42.18%

Income statement

Revenue (ttm)687.76M
Revenue per share (ttm)166.41
Quarterly revenue growth (yoy)13.50%
Gross profit (ttm)N/A
EBITDA 45k
Net income avi to common (ttm)-131.97M
Diluted EPS (ttm)-31.9300
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)36.8M
Total cash per share (mrq)8.74
Total debt (mrq)750.18M
Total debt/equity (mrq)602.37%
Current ratio (mrq)1.08
Book value per share (mrq)-25.05

Cash flow statement

Operating cash flow (ttm)-12.37M
Levered free cash flow (ttm)-9.69M